Journey Medical Corporation Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights

Journey Medical Corporation to Announce Second Quarter 2026 Financial Results on August 12, 2026

Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $130 Million Series B Financing